Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
about
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trialHypometabolism as a therapeutic target in Alzheimer's diseaseReduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional studyThe KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.Human gene therapy and imaging in neurological diseases.Statistical approaches to functional neuroimaging dataAltered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease.Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers.Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literatureCardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variationsArterial input function derived from pairwise correlations between PET-image voxelsThe influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.Evaluation of two automated methods for PET region of interest analysis.Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response.
P2860
Q21245063-2E6ABC99-1CC7-4B36-9EBC-E34F52C444D2Q21262020-5EB52225-4DE5-4599-9B53-B74BAEFF5A80Q25257069-0E1183FD-80D2-4640-AE99-B5669FE2AEBBQ30497430-A091939D-AB90-4E39-8CB8-6E3BAF04D787Q31023442-A614B596-D32D-42F1-BDFA-31D4B93216AAQ31135429-E71C2B69-A1CC-4EFE-B63C-FC928FC82011Q31146509-C80E5C5E-C67B-4904-BDB9-4F0CEBDAB1B1Q33460503-F149F338-5341-48F6-ADE4-BE52BF7E61D7Q34146458-4C1A0B10-A1BB-4FD9-96CE-AE4F54D2FC39Q35806684-C0A4AAD3-8B36-436F-9361-F970FED5DC16Q36575903-CE7CA329-EF44-4C8E-8F82-8F5137767D2CQ36795245-F2BB5C4A-1D8A-458C-9379-6E4F850CD725Q36994317-56B22BF2-9013-41EC-95C1-3F42C74E32F9Q37198894-381424FB-7146-476D-A79B-9D9C32D4CEE2Q37218110-B215AD42-26AB-4697-B51B-07C8345F8F20Q48747438-C037FB8F-E210-4058-BC4D-C30258F997F7Q50035045-A65ACB3A-6A90-4EC2-BD4F-1B663ED9687B
P2860
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
@ast
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
@en
type
label
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
@ast
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
@en
prefLabel
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
@ast
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
@en
P2093
P2860
P356
P1476
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
@en
P2093
Antonio Convit
Henry Rusinek
Lisa Mosconi
Susan De Santi
P2860
P304
P356
10.1586/14737175.4.5.831
P577
2004-09-01T00:00:00Z